Pharmafile Logo

Congenica

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

Blue Latitude Health

Genetic testing: nothing to write home about?

An issue of health literary and health motivation?

- PMLiVE

Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte

Alexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media

Medical information in precision medicine

Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine.

Blue Latitude Health

- PMLiVE

Chiesi targets patient adherence via mobile app

Initiative will see asthma and COPD patients receive device training support

- PMLiVE

Daily Brief: PRIME status for vaccine, NHS urged to adopt automation, Brexit votes loom

A rapid round up of pharma, biotech and healthcare news

- PMLiVE

Aptar Pharma advances digital offerings

Partners up with digital therapeutics company Propeller Health

- PMLiVE

Rosalind Franklin Institute invests £6m in disruptive technologies

Will open new AI-enabled research facility based in the UK

- PMLiVE

Biotech: it’s a people business

Nancy Hunter is the Marketing Director at a cutting-edge pharmaceutical company. Here she explains how a sharp focus on patients’ needs is driving a new operating model for marketing first-in-class...

Blue Latitude Health

Global mHealth market predicted to reach $58.8bn by 2020

And digital therapeutics could rival mainstream pharmaceutical products, according to a report

Is the pharma business model ready for precision medicine?

Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Blue Latitude Health

Boehringer partners with Bactevo on drug discovery

Bactevo will use its TIME platform to identify small molecule lead compounds

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links